Metoclopramide and Chemotherapy-Induced Emesis

  1. B. ROBERT MEYER, M.D.;
  2. MARGARET LEWIN, M.D.;
  3. MARK PASMANTIER, M.D.;
  4. DENNIS E. DRAYER, M.D.; and
  5. MARCUS M. REIDENBERG, M.D.
  1. Cornell University Medical College;
    New York, NY 10021

    Excerpt

    To the editor: Benzodiazepines have been reported to be useful in the control of chemotherapy-induced emesis (1-3). Metoclopramide at doses of 2 mg/kg body weight every 2 hours is the single best agent for the control of cisplatin-induced emesis (4). We did a clinical trial to assess the usefulness of adding diazepam to a standard metoclopramide regimen for the control of cisplatin-induced emesis.

    Eligible patients were receiving cisplatin at doses of 60 to 100 mg/m2 body surface area as part of a combination chemotherapy regimen and had no contraindication to either metoclopramide or diazepam. Metoclopramide dosage was 2 mg/kg every

    « Previous | Next Article »Table of Contents